您的位置: 首页 > 农业专利 > 详情页

Treatment of Glaucoma Using Laquinimod
专利权人:
Revital Etzyoni;Ron Neumann
发明人:
Ron Neumann,Revital Etzyoni
申请号:
US15290461
公开号:
US20170027927A1
申请日:
2016.10.11
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The subject invention provides a method of treating a subject afflicted with glaucoma, suffering from retinal ganglion cell (RGC) loss or damage, or elevated intraocular pressure (IOP), or of reducing RGC loss or damage, or reducing IOP in a subject, comprising administering to the subject an amount of laquinimod effective to treat the subject, to reduce RGC loss or damage, or to reduce IOP in the subject. Provide also is a pharmaceutical composition, a package and a therapeutic package for treating a subject afflicted with glaucoma.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充